OPKO Health, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
OPKO Health, Inc. (OPK) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$907.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-28
- OPKO Health, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$907.00K, a 104.47% decline year-over-year.
- OPKO Health, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$6.47M, a 158.15% decline year-over-year.
- OPKO Health, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $4.45M.
- OPKO Health, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was -$736.00K, a 110.46% decline year-over-year.
- OPKO Health, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $35.11M.
- OPKO Health, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$18.10M, a 441.96% decline from fiscal 2023.
- OPKO Health, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $5.29M.
- OPKO Health, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$12.83M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$907.00K 10-Q/A · filed 2026-08-28 | -$7.38M 10-Q/A · filed 2026-08-28 | -$2.93M derived: sum of 3 quarters · filed 2026-08-28 | -$3.66M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2026-03-31 | -$6.47M 10-Q/A · filed 2026-08-28 | -$2.02M derived: sum of 2 quarters · filed 2026-08-28 | -$2.76M derived: sum of 3 quarters · filed 2026-08-28 | $17.52M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-12-31 | $4.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.71M derived: sum of 2 quarters · filed 2026-02-26 | $23.99M derived: sum of 3 quarters · filed 2026-08-28 | $35.11M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$736.00K 10-Q · filed 2025-10-29 | $19.54M derived: sum of 2 quarters · filed 2026-08-28 | $30.66M 10-Q · filed 2025-10-29 | $14.15M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-06-30 | $20.28M 10-Q/A · filed 2026-08-28 | $31.40M 10-Q/A · filed 2026-08-28 | $14.88M derived: sum of 3 quarters · filed 2026-08-28 | $21.92M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-03-31 | $11.12M 10-Q/A · filed 2026-08-28 | -$5.39M derived: sum of 2 quarters · filed 2026-08-28 | $1.65M derived: sum of 3 quarters · filed 2026-08-28 | $189.00K derived: sum of 4 quarters · filed 2026-08-28 | |
| 2024-12-31 | -$16.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.48M derived: sum of 2 quarters · filed 2026-02-26 | -$10.94M derived: sum of 3 quarters · filed 2026-02-26 | -$18.10M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $7.04M 10-Q · filed 2025-10-29 | $5.58M derived: sum of 2 quarters · filed 2025-10-29 | -$1.58M 10-Q · filed 2025-10-29 | $6.88M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$1.46M 10-Q · filed 2025-07-31 | -$8.62M 10-Q · filed 2025-07-31 | -$157.00K derived: sum of 3 quarters · filed 2026-02-26 | -$9.71M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$7.17M 10-Q · filed 2025-05-01 | $1.30M derived: sum of 2 quarters · filed 2026-02-26 | -$8.25M derived: sum of 3 quarters · filed 2026-02-26 | -$7.58M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $8.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.09M derived: sum of 2 quarters · filed 2026-02-26 | -$419.00K derived: sum of 3 quarters · filed 2026-02-26 | $5.29M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$9.55M 10-Q · filed 2024-11-07 | -$8.88M derived: sum of 2 quarters · filed 2024-11-07 | -$3.17M 10-Q · filed 2024-11-07 | $11.53M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $669.00K 10-Q · filed 2024-08-07 | $6.38M 10-Q · filed 2024-08-07 | $21.08M derived: sum of 3 quarters · filed 2025-03-03 | $12.23M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $5.71M 10-Q · filed 2024-05-07 | $20.41M derived: sum of 2 quarters · filed 2025-03-03 | $11.56M derived: sum of 3 quarters · filed 2025-03-03 | -$6.20M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2022-12-31 | $14.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $5.85M derived: sum of 2 quarters · filed 2025-03-03 | -$11.91M derived: sum of 3 quarters · filed 2025-03-03 | -$12.83M 10-K · filed 2025-03-03 | |
| 2022-09-30 | -$8.86M 10-Q · filed 2023-11-06 | -$26.61M derived: sum of 2 quarters · filed 2023-11-06 | -$27.53M 10-Q · filed 2023-11-06 | -$38.10M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2022-06-30 | -$17.76M 10-Q · filed 2023-08-03 | -$18.68M 10-Q · filed 2023-08-03 | -$29.25M derived: sum of 3 quarters · filed 2024-03-01 | -$39.24M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2022-03-31 | -$920.00K 10-Q · filed 2023-05-03 | -$11.49M derived: sum of 2 quarters · filed 2024-03-01 | -$21.48M derived: sum of 3 quarters · filed 2024-03-01 | -$18.12M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2021-12-31 | -$10.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$20.56M derived: sum of 2 quarters · filed 2024-03-01 | -$17.20M derived: sum of 3 quarters · filed 2024-03-01 | -$26.27M 10-K · filed 2024-03-01 | |
| 2021-09-30 | -$9.99M 10-Q · filed 2022-11-08 | -$6.63M derived: sum of 2 quarters · filed 2022-11-08 | -$15.70M 10-Q · filed 2022-11-08 | -$2.47M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | $3.36M 10-Q · filed 2022-08-04 | -$5.71M 10-Q · filed 2022-08-04 | $7.52M derived: sum of 3 quarters · filed 2023-02-27 | $15.82M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | -$9.07M 10-Q · filed 2022-05-09 | $4.16M derived: sum of 2 quarters · filed 2023-02-27 | $12.46M derived: sum of 3 quarters · filed 2023-02-27 | $16.89M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | $13.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $21.53M derived: sum of 2 quarters · filed 2023-02-27 | $25.96M derived: sum of 3 quarters · filed 2023-02-27 | $17.84M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $8.30M 10-Q · filed 2021-10-28 | $12.74M derived: sum of 2 quarters · filed 2021-10-28 | $4.62M 10-Q · filed 2021-10-28 | $11.32M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $4.43M 10-Q · filed 2021-07-29 | -$3.68M 10-Q · filed 2021-07-29 | $3.02M derived: sum of 3 quarters · filed 2022-03-01 | -$5.40M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$8.12M 10-Q · filed 2021-04-28 | -$1.41M derived: sum of 2 quarters · filed 2022-03-01 | -$9.84M derived: sum of 3 quarters · filed 2022-03-01 | -$6.96M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$1.72M derived: sum of 2 quarters · filed 2022-03-01 | $1.16M derived: sum of 3 quarters · filed 2022-03-01 | -$1.94M 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$8.42M 10-Q · filed 2020-10-29 | -$5.54M derived: sum of 2 quarters · filed 2020-10-29 | -$8.64M 10-Q · filed 2020-10-29 | -$20.51M derived: sum of 4 quarters · filed 2020-10-29 | |
| 2019-06-30 | $2.88M 10-Q · filed 2020-07-31 | -$220.00K 10-Q · filed 2020-07-31 | -$12.09M derived: sum of 3 quarters · filed 2020-07-31 | -$12.22M derived: sum of 4 quarters · filed 2020-07-31 | |
| 2019-03-31 | -$3.10M 10-Q · filed 2020-05-06 | -$14.97M derived: sum of 2 quarters · filed 2020-05-06 | -$15.10M derived: sum of 3 quarters · filed 2020-05-06 | -$27.57M derived: sum of 4 quarters · filed 2020-05-06 | |
| 2018-12-31 | -$11.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$12.00M derived: sum of 2 quarters · filed 2020-03-02 | -$24.47M derived: sum of 3 quarters · filed 2020-03-02 | -$19.60M 10-K · filed 2020-03-02 | -$14.73M 10-K · filed 2019-03-01 |
| 2018-09-30 | -$134.00K 10-Q · filed 2019-11-05 | -$12.60M derived: sum of 2 quarters · filed 2019-11-05 | -$7.73M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | -$12.46M 10-Q · filed 2019-08-07 | -$7.60M 10-Q · filed 2019-08-07 | |||
| 2018-03-31 | $4.87M 10-Q · filed 2019-05-08 | ||||
| 2017-12-31 | $26.48M 10-K · filed 2019-03-01 | ||||
| 2016-12-31 | -$4.47M 10-K · filed 2019-03-01 | ||||
| 2015-12-31 | -$10.14M 8-K · filed 2019-01-29 | ||||
| 2014-12-31 | -$15.81M 10-K · filed 2017-03-01 | ||||
| 2013-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $588.00K derived: sum of 2 quarters · filed 2016-02-29 | -$4.67M derived: sum of 3 quarters · filed 2016-02-29 | -$3.94M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $407.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$4.86M derived: sum of 2 quarters · filed 2013-11-12 | -$4.12M 10-Q · filed 2013-11-12 | ||
| 2013-06-30 | -$5.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$4.53M 10-Q · filed 2013-08-09 | |||
| 2013-03-31 | $737.00K 10-Q · filed 2013-05-10 | ||||
| 2012-12-31 | $6.45M 10-K · filed 2015-02-27 | ||||
| 2011-12-31 | -$2.01M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |